Parsons Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Hold |
3,169
| – | – | 0.02% | 404 |
|
|
2025
Q1 | $230K | Sell |
3,169
-114
| -3% | -$8.26K | 0.01% | 406 |
|
|
2024
Q4 | $243K | Sell |
3,283
-486
| -13% | -$36K | 0.01% | 409 |
|
|
2024
Q3 | $249K | Hold |
3,769
| – | – | 0.02% | 403 |
|
|
2024
Q2 | $348K | Sell |
3,769
-67
| -2% | -$6.19K | 0.02% | 353 |
|
|
2024
Q1 | $367K | Sell |
3,836
-9
| -0.2% | -$860 | 0.03% | 353 |
|
|
2023
Q4 | $293K | Buy |
3,845
+12
| +0.3% | +$915 | 0.02% | 378 |
|
|
2023
Q3 | $266K | Buy |
3,833
+8
| +0.2% | +$554 | 0.02% | 375 |
|
|
2023
Q2 | $361K | Sell |
3,825
-8
| -0.2% | -$755 | 0.03% | 344 |
|
|
2023
Q1 | $317K | Sell |
3,833
-115
| -3% | -$9.51K | 0.03% | 354 |
|
|
2022
Q4 | $295K | Buy |
3,948
+16
| +0.4% | +$1.19K | 0.02% | 359 |
|
|
2022
Q3 | $325K | Buy |
3,932
+23
| +0.6% | +$1.9K | 0.03% | 336 |
|
|
2022
Q2 | $372K | Buy |
3,909
+52
| +1% | +$4.95K | 0.03% | 324 |
|
|
2022
Q1 | $454K | Buy |
3,857
+89
| +2% | +$10.5K | 0.03% | 318 |
|
|
2021
Q4 | $488K | Sell |
3,768
-1
| -0% | -$130 | 0.04% | 315 |
|
|
2021
Q3 | $427K | Sell |
3,769
-8
| -0.2% | -$906 | 0.03% | 315 |
|
|
2021
Q2 | $391K | Buy |
3,777
+2
| +0.1% | +$207 | 0.03% | 322 |
|
|
2021
Q1 | $316K | Buy |
3,775
+3
| +0.1% | +$251 | 0.03% | 338 |
|
|
2020
Q4 | $344K | Buy |
3,772
+1
| +0% | +$91 | 0.03% | 302 |
|
|
2020
Q3 | $301K | Buy |
3,771
+3
| +0.1% | +$239 | 0.03% | 296 |
|
|
2020
Q2 | $260K | Hold |
3,768
| – | – | 0.03% | 305 |
|
|
2020
Q1 | $237K | Sell |
3,768
-735
| -16% | -$46.2K | 0.03% | 283 |
|
|
2019
Q4 | $350K | Buy |
4,503
+597
| +15% | +$46.4K | 0.04% | 279 |
|
|
2019
Q3 | $286K | Sell |
3,906
-234
| -6% | -$17.1K | 0.03% | 293 |
|
|
2019
Q2 | $255K | Sell |
4,140
-3
| -0.1% | -$185 | 0.03% | 306 |
|
|
2019
Q1 | $264K | Buy |
+4,143
| New | +$264K | 0.03% | 301 |
|